ATE283279T1 - Therapeutische inhaltsstoffe - Google Patents
Therapeutische inhaltsstoffeInfo
- Publication number
- ATE283279T1 ATE283279T1 AT94915474T AT94915474T ATE283279T1 AT E283279 T1 ATE283279 T1 AT E283279T1 AT 94915474 T AT94915474 T AT 94915474T AT 94915474 T AT94915474 T AT 94915474T AT E283279 T1 ATE283279 T1 AT E283279T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- biologically
- peptides
- therapeutic ingredients
- pharmaceutical compositions
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000004615 ingredient Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 108010033276 Peptide Fragments Proteins 0.000 abstract 1
- 101710192141 Protein Nef Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL886193 | 1993-05-18 | ||
PCT/AU1994/000254 WO1994026776A1 (en) | 1993-05-18 | 1994-05-18 | Therapeutic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE283279T1 true ATE283279T1 (de) | 2004-12-15 |
Family
ID=3776902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94915474T ATE283279T1 (de) | 1993-05-18 | 1994-05-18 | Therapeutische inhaltsstoffe |
Country Status (7)
Country | Link |
---|---|
US (2) | US5962635A (de) |
EP (1) | EP0717752B1 (de) |
JP (1) | JP3699112B2 (de) |
AT (1) | ATE283279T1 (de) |
CA (1) | CA2163212C (de) |
DE (1) | DE69434151D1 (de) |
WO (1) | WO1994026776A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10500281A (ja) * | 1994-02-14 | 1998-01-13 | ザ マクファーレーン バーネット センター フォー メディカル リサーチ リミテッド | 非病原性hiv−1種 |
WO1998013377A1 (en) * | 1996-03-06 | 1998-04-02 | Biomolecular Research Institute Ltd. | Cytotoxic peptides |
US20050033022A1 (en) * | 1997-09-26 | 2005-02-10 | Smithkline Beecham Biologicals Sa | Fusion proteins comprising HIV-1 Tat and/or Nef proteins |
DE02708018T1 (de) * | 2001-03-09 | 2004-09-30 | Gene Stream Pty. Ltd. | Neue expressionsvektoren |
GB0417494D0 (en) * | 2004-08-05 | 2004-09-08 | Glaxosmithkline Biolog Sa | Vaccine |
CA2577183C (en) * | 2004-08-17 | 2014-02-18 | Institut Gustave Roussy | Mutated hiv nef for modulating immunity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0349354A1 (de) * | 1988-04-01 | 1990-01-03 | Institut Pasteur | Peptide PF10 bis PF19 von einem Retrovirus HIV, Verfahren zur Synthese dieser Peptide und ihre Verwendung, insbesondere zur Diagnose |
US5221610A (en) * | 1988-05-26 | 1993-06-22 | Institut Pasteur | Diagnostic method and composition for early detection of HIV infection |
JPH08500481A (ja) * | 1992-05-11 | 1996-01-23 | リボザイム・ファーマシューティカルズ・インコーポレーテッド | ウイルスの複製を阻害するための方法および薬剤 |
GB9311043D0 (en) * | 1993-05-28 | 1993-07-14 | Medical Res Council | Inhibitors of nef-cd4 binding |
-
1994
- 1994-05-18 CA CA002163212A patent/CA2163212C/en not_active Expired - Fee Related
- 1994-05-18 AT AT94915474T patent/ATE283279T1/de not_active IP Right Cessation
- 1994-05-18 JP JP52474294A patent/JP3699112B2/ja not_active Expired - Fee Related
- 1994-05-18 DE DE69434151T patent/DE69434151D1/de not_active Expired - Lifetime
- 1994-05-18 WO PCT/AU1994/000254 patent/WO1994026776A1/en active IP Right Grant
- 1994-05-18 EP EP94915474A patent/EP0717752B1/de not_active Expired - Lifetime
- 1994-05-18 US US08/553,271 patent/US5962635A/en not_active Expired - Fee Related
-
1999
- 1999-04-20 US US09/285,070 patent/US6197583B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0717752A4 (de) | 1997-08-20 |
CA2163212A1 (en) | 1994-11-24 |
JPH09501143A (ja) | 1997-02-04 |
DE69434151D1 (de) | 2004-12-30 |
WO1994026776A1 (en) | 1994-11-24 |
JP3699112B2 (ja) | 2005-09-28 |
US5962635A (en) | 1999-10-05 |
US6197583B1 (en) | 2001-03-06 |
CA2163212C (en) | 2004-07-13 |
EP0717752B1 (de) | 2004-11-24 |
EP0717752A1 (de) | 1996-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
ATE549028T1 (de) | Stabile analoga von glp-1 | |
NO952744D0 (no) | Cytokinbegrensende midler | |
RU95115239A (ru) | Аналог эритропоэтина | |
ATE165100T1 (de) | Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen | |
DZ2509A1 (fr) | Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant. | |
NL300830I1 (nl) | Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten | |
PT848720E (pt) | Antagonistas da actividade oncogenica da proteina mdm2 e sua utilizacao no tratamento de cancros | |
ATE280777T1 (de) | Bradykinin-antagonist peptide mit n- substituierten glycinen | |
BG104266A (en) | Aminoterminally incised mcp-2 as haemokin antagonists | |
DE602004028246D1 (de) | Analoga von peptiden der relaxin-superfamilie | |
DK1079849T3 (da) | Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning | |
ATE199160T1 (de) | Hochaktive vip - antagonisten | |
ATE10364T1 (de) | Retro-inverso analoga von c-terminalen pentaund hexapeptiden der verbindung p. | |
BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
ATE69727T1 (de) | Zusammensetzung zur behandlung von an haemophilia- a-inhibitor leidenden kranken. | |
ATE283279T1 (de) | Therapeutische inhaltsstoffe | |
ATE177843T1 (de) | Peptomere mit erhöhter immunogenizität | |
HUP0001458A2 (hu) | Specifikus hasnyálmirigy lipáz inhibitor hatású peptidek, ezeket tartalmazó gyógyszerkészítmények és diagnosztikai reagensek, valamint ezek alkalmazása | |
CA2370098A1 (en) | Human beta-trcp protein | |
ATE42308T1 (de) | Pharmakologisch aktive peptide. | |
ATE390440T1 (de) | Neuroaktive peptide | |
CA2057612A1 (en) | Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof | |
DE69328488D1 (de) | Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus | |
ES2061908T3 (es) | Antagonistas competitivos de gonadoliberina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |